Emami Limited (BOM: 531162)

India flag India · Delayed Price · Currency is INR
823.75
-3.60 (-0.44%)
At close: Sep 10, 2024
45.00%
Market Cap 359.57B
Revenue (ttm) 36.59B
Net Income (ttm) 7.38B
Shares Out 436.50M
EPS (ttm) 16.93
PE Ratio 48.66
Forward PE 39.68
Dividend 8.00 (0.97%)
Ex-Dividend Date n/a
Volume 4,707
Open 826.25
Previous Close 827.35
Day's Range 813.10 - 846.15
52-Week Range 417.55 - 859.20
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Oct 25, 2024

About Emami

Emami Limited manufactures and markets personal and healthcare products in India and internationally. It provides ayurvedic antiseptic cream, prickly heat powder, doodh kesar body lotion, aloe neem lotion, vasocare herbal petroleum jelly, coconut oil, aloe vera gel, and hygiene products under the Boroplus brand; cool oil, extra thanda, gold ayurvedic oil, therapy ayurvedic body massage and stress relief oil, maxx cool talc, and cool talc under the Navratna brand; and balm, balm ultra-power, quick relief roll-on, ortho vedic oil, ointment, relie... [Read more]

Industry Perfumes, Cosmetics, and Other Toilet Preparations
Founded 1974
Employees 3,289
Stock Exchange Bombay Stock Exchange
Ticker Symbol 531162
Full Company Profile

Financial Performance

In 2023, Emami's revenue was 35.78 billion, an increase of 5.06% compared to the previous year's 34.06 billion. Earnings were 7.24 billion, an increase of 13.13%.

Financial Statements

News

Bangladesh ops slowly stabilising, says Emami

Kolkata: The Bangladesh operations of Emami Ltd were gradually stabilising and, like Sri Lanka, the FMCG major did not foresee any big impact, CFO N B.

14 days ago - The Times of India